Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06865365
PHASE4

Preoperative Use of Liraglutide Additionally to Common Dietological Measures as Opposed to Dietological Measures Alone

Sponsor: Medical University of Vienna

View on ClinicalTrials.gov

Summary

The aim of the study is to investigate the effects of preoperative Saxenda (liraglutide). There are two groups, one group receives Saxena in addition to dietary measures when first seeking the operation, one group only diet. The investigator is researching how much additional preoperative weight loss is possible with the drug admitted preoperatively.

Official title: Prospective, Randomized, Controlled Trial of Preoperative Use of Saxenda (Liraglutide) Additionally to Common Dietological Measures as Opposed to Dietological Measures Alone

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

72

Start Date

2025-05-01

Completion Date

2028-02-01

Last Updated

2025-03-21

Healthy Volunteers

No

Interventions

DRUG

Liraglutide daily (0.6-3.0mg, highest tolerable dose) additional to dietological measures and lifestyle optimization suggestions

Liraglutide daily (0.6-3.0mg, highest tolerable dose) as additional preoperative method for weight loss

BEHAVIORAL

Dietologic measures and lifestyle optimization for weight loss

all subjects will receive dietary measures and lifestyle opitmization suggestions in order to drop weight preoperatively.